Pharma Journalist -

Tempus announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical stage biopharmaceutical company, in support of its ongoing Phase…
Read More...

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today issued the following announcement regarding data from two real-world evidence studies…
Read More...

Enzo Biochem, Inc. announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York. The launch event…
Read More...

Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies.…
Read More...

CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, announced the latest funding award under…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases…
Read More...

BioLink Life Sciences of Cary, North Carolina, announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the development of…
Read More...

Pfizer Inc. announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID),…
Read More...

Myonex announced the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports…
Read More...